ScreenCell, 75012 Paris, France.
Anticancer Res. 2011 Feb;31(2):427-41.
Circulating tumor cells (CTCs) likely derive from clones in the primary tumor, suggesting that they can be used for all biological tests applying to the primary cells.
The ScreenCell® devices are single-use and low-cost innovative devices that use a filter to isolate and sort tumor cells by size.
The ScreenCell® Cyto device is able to isolate rare, fixed, tumor cells, with a high recovery rate. Cells are well preserved morphologically. Immunocytochemistry and FISH assays can be performed directly on the filter. The ScreenCell® CC device allows isolation of live cells able to grow in culture. High quality genetic materials can be obtained directly from tumor cells isolated on the ScreenCell® MB device filter.
Due to their reduced size, versatility, and capacity to isolate CTCs within minutes, the ScreenCell® devices may be able to simplify and improve non-invasive access to tumor cells.
循环肿瘤细胞（CTCs）可能来源于原发性肿瘤中的克隆，这表明它们可以用于所有适用于原发性细胞的生物学检测。
ScreenCell® 设备是一种即用型、低成本的创新设备，它使用过滤器根据大小分离和分选肿瘤细胞。
ScreenCell® Cyto 设备能够分离出罕见的、固定的肿瘤细胞，且具有较高的回收率。细胞在形态上得到很好的保存。免疫细胞化学和 FISH 检测可以直接在滤器上进行。ScreenCell® CC 设备可以分离出能够在培养中生长的活细胞。可以直接从 ScreenCell® MB 设备滤器上分离的肿瘤细胞中获得高质量的遗传物质。
由于 ScreenCell® 设备体积小、用途广泛，并且能够在数分钟内分离 CTCs，因此它们可能能够简化和改善对肿瘤细胞的非侵入性获取。
